Home
Alivus Life Sciences

Alivus Life Sciences Market Share Analysis for August 2026

Alivus Life Sciences is a leading developer and manufacturer of select high value, non-commoditized Active Pharmaceutical Ingredients (APIs)

Industry: N/A

Domainalivus.com

Year Founded2019

Employees1001 - 5000

Annual Revenue--

Alivus Life Sciences

Alivus Life Sciences (including company regionals)

alivus.com

See more website traffic and engagement information

Total visits to Alivus Life Sciences's top domains

Understand Alivus Life Sciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

alivus.com4.3K

See more with Sales Intelligence

Avg. visit duration in Alivus Life Sciences's top domains

Analyze Alivus Life Sciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

alivus.com00:00:25

See more with Sales Intelligence

Avg. pageviews on Alivus Life Sciences's top domains

See how Alivus Life Sciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

alivus.com1.63

See more with Sales Intelligence

Alivus Life Sciences top competitors by domain

Top similar sites in August 2026, ranked by their affinity

cheplapharm.comCompany NameCheplapharm AGEmployees501 - 1000HQGermany, GreifswaldAnnual revenue$15M - $25MTotal visits30KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Alivus Life Sciences

These are the website technologies, by industry, used by Alivus Life Sciences top domains

Payment & Currencies (3)

PayPal

Content Management System (2)

WordPress

Email Services (2)

GoDaddy Email

Widget (2)

Twemoji

More Technologies

6

See all

News & Signals from Alivus Life Sciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlivus Life Sciences Limited has earnings of $16.9M.Net profit of Alivus Life Sciences rose 14.65% to Rs 162.66 crore in the quarter ended March 2026 as against Rs 141.87 crore during the previous quarter ended March 2025.

NewsSeva Sa partners with Alivus Life Sciences Limited.Organized by Seva Sahayog Foundation in partnership with Alivus Life Sciences under Project Vigyasa, the initiative illustrates how cross-sector collaboration can meaningfully influence science education at the grassroots level.